NCT00312273View on ClinicalTrials.gov

Aminophylline in Bradyasystolic Cardiac Arrest

PHASE2CompletedINTERVENTIONAL
Enrollment

966

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

July 31, 2004

Conditions
Cardiac Arrest
Interventions
DRUG

Aminophylline (250mg IV +/- a second dose of 250mg IV)

Trial Locations (1)

V5Z 1M9

Vancouver General Hospital, Vancouver

All Listed Sponsors
collaborator

Heart and Stroke Foundation of Canada

OTHER

collaborator

Vancouver Coastal Health Research Institute

OTHER

lead

Vancouver General Hospital

OTHER

NCT00312273 - Aminophylline in Bradyasystolic Cardiac Arrest | Biotech Hunter | Biotech Hunter